Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2019 | Story Ngang Carol | Photo Stephen Collett
International conference delegates
International delegates attending the International Conference on the Right to Development hosted on the Bloemfontein Campus.

The International Conference on the Right to Development was held in Bloemfontein for the first time from 25 to 27 September 2019, hosted by the Free State Centre for Human Rights at the University of the Free State. This is the third in the international conference series launched in 2017 with the aim of advancing the right to development both in Africa and internationally. This year’s conference follows the previous two that were held at the Centre for Human Rights, University of Pretoria, in September 2017 and August 2018.  

Based on the theme, ‘The right to development and natural resource ownership’, the 3rd International Conference on the Right to Development offered the forum and opportunity to participants from a diversity of backgrounds and disciplines to interact and share knowledge on their research outputs, which extensively explored questions on how natural resource ownership could contribute to the realisation of the right to development. The keynote address was delivered by Prof John C Mubangizi, Dean of the Faculty of Law at the University of the Free State. 

The three-day conference registered a total of 35 participants and 27 presentations out of the 33 that were scheduled. Participants came from different countries, including South Africa, Botswana, Zimbabwe, the Democratic Republic of the Congo, Cameroon, Nigeria, Ghana, Kenya, Uganda, Ethiopia, and the United Kingdom. Some of those who were unable to attend had the opportunity to present their papers through Skype. The presentations stimulated exciting and robust debates. 

The International Conference Series on the Right to Development is jointly organised and co-sponsored by the Centre for Human Rights, University of Pretoria; the Thabo Mbeki African Leadership Institute, University of South Africa; and the Free State Centre for Human Rights, University of the Free Sate. In its three years of existence, it has progressively established a steady track record of publications, including journal articles in special editions of selected journals and collections of chapters in edited volumes. 

The next (fourth) conference is intended to be much bigger and is scheduled to take place in Kigali, Rwanda, in 2021. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept